rs121913090
Variant summary
Our verdict is Likely pathogenic. Variant got 6 ACMG points: 6P and 0B. PM1PM2PP3_Moderate
The NM_021870.3(FGG):c.1001A>T(p.Asn334Ile) variant causes a missense change. The variant allele was found at a frequency of 0.0000062 in 1,613,972 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Another nucleotide change resulting in same amino acid change has been previously reported as Likely benignin UniProt. Another variant affecting the same amino acid position, but resulting in a different missense (i.e. N334K) has been classified as Uncertain significance.
Frequency
Consequence
NM_021870.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
FGG | NM_021870.3 | c.1001A>T | p.Asn334Ile | missense_variant | 8/9 | ENST00000336098.8 | |
FGG | NM_000509.6 | c.1001A>T | p.Asn334Ile | missense_variant | 8/10 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
FGG | ENST00000336098.8 | c.1001A>T | p.Asn334Ile | missense_variant | 8/9 | 2 | NM_021870.3 |
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152138Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000159 AC: 4AN: 251356Hom.: 0 AF XY: 0.0000147 AC XY: 2AN XY: 135844
GnomAD4 exome AF: 0.00000410 AC: 6AN: 1461716Hom.: 0 Cov.: 31 AF XY: 0.00000275 AC XY: 2AN XY: 727160
GnomAD4 genome AF: 0.0000263 AC: 4AN: 152256Hom.: 0 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74450
ClinVar
Submissions by phenotype
not provided Uncertain:2
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Sep 22, 2022 | This variant is present in population databases (rs121913090, gnomAD 0.02%). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt FGG protein function. ClinVar contains an entry for this variant (Variation ID: 16365). This variant is also known as Asn308Ile. This missense change has been observed in individual(s) with dysfibrinogenemia (PMID: 2328317, 3175983). This sequence change replaces asparagine, which is neutral and polar, with isoleucine, which is neutral and non-polar, at codon 334 of the FGG protein (p.Asn334Ile). - |
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Jan 26, 2024 | In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Also known as Asn308Ile or Fibrinogen Baltimore III; This variant is associated with the following publications: (PMID: 2328317, 33260935, 3175983) - |
FIBRINOGEN BALTIMORE 3 Other:1
other, no assertion criteria provided | literature only | OMIM | Sep 26, 2014 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at